The Role of Surgical Approach on Residual Limping After Total Hip Arthroplasty

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age40-80
SponsorSahlgrenska University Hospital

About this trial

Residual limping after total hip arthroplasty is empirically associated with the use of lateral approach but has been reported in litterature even with the use of posterior approach. The purpose of this clinical trial is to compare the risk of residual limping one year after total hip arthropasty between lateral and posterior approach.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Primary unilateral osteoarthritis of the hip scheduled for total hip arthroplasty.

Ability to understand and write swedish.

Disqualifiers

Impaired funktion of the contralateral hip or knees causing limping.

Neuromuscular diseases

Postoperative leg length discrepancy excceding 1 cm

Postoperative discrepancy in femoral offset exceeding 25% of the femoral offset of the contralateral hip.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Lateral approach

    Procedure/Surgery

    Total hip arthroplasty performed through a lateral surgical approach (Gammer)

  • Posterior approach

    Procedure/Surgery

    Total hip arthroplasty performed through a posterior surgical approach (Moore)

Treatment groups

580 Participants
are divided into 2 treatment groups
Group A: Lateral approachActive comparator 1 intervention
Group B: Posterior approachActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Trendelenburg sign as binary variable (positive/negative)

Trendelenburg sign negative if the pelvis remains horisontal while standing only on the operated leg with both arms in anatomical postion. If the pelvismcannot be kept horisontal and tilts towards the kontralateral hip the Trendelenburgs sign is regarded as positive.

Time frame
At 12 months after intervention

Secondary outcomes

1

Dislocation

Incidens of postoperative dislocation

Time frame
Within 12 months from intervention
2

Intraoperative blood loss

Bleeding during total hip arthroplasty measured in ml

Time frame
Intraoperative
3

Periprosthetic infection

Incidens of deep surgical wound infection

Time frame
Within 12 months from intervention
4

Oxford Hip Score

Patient-reported hip function measured in a scale of 0-48

Time frame
At 3 months after intervention

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sahlgrenska University Hospital

Lead sponsor

Vastra Gotaland Region

Collaborator